Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1006
Embargo will expire:
22-Feb-2018 4:00 PM EST
Released to reporters:
16-Feb-2018 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Feb-2018 4:00 PM EST

Channels:

All Journal News, Family and Parenting, OBGYN

Add Images
or Multimedia

  • Embargo expired:
    15-Feb-2018 12:00 PM EST

Article ID: 689598

Working in Harmony: New Insights Into How Packages of DNA Orchestrate Development

Huntsman Cancer Institute at the University of Utah

New research from Huntsman Cancer Institute at the University of Utah illuminates aspects of how an early embryo, the product of fertilization of a female egg cell by a male sperm cell, can give rise to all the many cell types of the adult animal.

Released:
15-Feb-2018 12:00 PM EST
EXPERT AVAILABLE
Add to Favorites

Channels:

All Journal News, Cell Biology, Genetics, OBGYN, Cell (journal)

Add Images
or Multimedia

Article ID: 689595

Asthma Medication Linked to Infertility in Women

University of Adelaide

Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to international research led by the University of Adelaide.

Released:
15-Feb-2018 9:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Asthma, OBGYN, Respiratory Diseases and Disorders

GettyImages-618185516.jpg

Article ID: 689592

Rooming-in Program Launched at Intermountain Medical Center to Enhance Bonding Between Moms and Babies

Intermountain Medical Center

Mothers and babies belong together — which is why Intermountain Medical Center in Salt Lake City has launched a rooming-in program to support early bonding between mothers and newborns.

Released:
15-Feb-2018 5:30 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment
JuliaSchwarzRashmiRamachandran.jpg

Article ID: 689558

Cutting Off Cervical Cancer’s Fuel Supply Stymies Tumors

Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have shown that cervical tumors that don’t respond to radiation may be vulnerable to therapies that also attack the cancer’s fuel supply.

Released:
14-Feb-2018 2:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, OBGYN, Women's Health

Chlamydia-large.gif

Article ID: 689469

Scientists Identify Immune Cascade that Fuels Complications, Tissue Damage in Chlamydia Infections

Harvard Medical School

Research in mice pinpoints immune mechanism behind tissue damage and complications of chlamydia infection, the most common sexually transmitted disease in the United States. Separate immune mechanisms drive bacterial clearance versus immune-mediated tissue damage and subsequent disease. Therapies are needed to avert irreversible reproductive organ damage that can arise as a result of silent infections that go untreated.

Released:
13-Feb-2018 12:35 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Infectious Diseases, OBGYN, Women's Health, Immunology, PNAS, Local - Massachusetts, Local - Boston Metro

Dey_NatComm_pregnancy.jpg
  • Embargo expired:
    9-Feb-2018 5:00 AM EST

Article ID: 689207

Direct Link Between Glands and Implanting Embryos Critical to Pregnancy

Cincinnati Children's Hospital Medical Center

Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy—offering clues to unsolved questions in pregnancy. Investigators report Feb. 9 in Nature Communications they demonstrated in mice that glands in the uterus must link and communicate directly with the embryo so it will implant and begin pregnancy.

Released:
8-Feb-2018 10:30 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment
Wherryheadshotmostrecentasof2018.jpg

Article ID: 689268

Penn Immunologist Awarded SU2C Funding to Lead Team-Based Investigation of Gynecologic Cancer Therapies

Perelman School of Medicine at the University of Pennsylvania

E. John Wherry, PhD, a cancer and immunology researcher at the Perelman School of Medicine at the University of Pennsylvania and one of the most highly cited investigators in his field, has been awarded a “Convergence 2.0” research grant by Stand Up to Cancer (SU2C) to investigate immune system response to cancers.

Released:
8-Feb-2018 3:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, OBGYN, All Journal News, Local - Pennsylvania

Add Images
or Multimedia

  • Embargo expired:
    7-Feb-2018 4:00 PM EST

Article ID: 688917

What Happens When Women Stop MS Treatment During Pregnancy?

American Academy of Neurology (AAN)

Two new studies look at the effects of stopping the newer, stronger drug natalizumab for multiple sclerosis (MS) during pregnancy. Natalizumab is generally prescribed for people with MS who have not responded to or cannot tolerate other treatments for MS as it can have a rare but potentially fatal side effect.

Released:
2-Feb-2018 3:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Neuro, OBGYN, Pharmaceuticals, Women's Health, Neurology (journal), All Journal News

Add Images
or Multimedia

Article ID: 649790

Cell Phone Radiation and Tumors, World Cancer Day 2018, Gut Bacteria and Colon Cancer, and More in the Cancer News Source

Newswise

Click here to go directly to the Cancer News Source

Released:
6-Feb-2018 3:45 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Biotech, Blood Disorders, Bone Health, Cancer, Cell Biology, Chemistry, Children's Health, Complementary Medicine, Dermatology, Genetics, Healthcare, Immunology, Drug Resistance, Infectious Diseases, Kidney Disease, Men's Health, Mental Health, Military Health, Mindfulness, Neuro, Nursing, Nutrition, OBGYN, Oral Health, Pain, Personalized Medicine, Pharmaceuticals


Showing results

110 of 1006





Chat now!